Gene expression involves transcription, translation and the turnover of mRNAs and proteins. The degree to which protein abundances scale with mRNA levels and the implications in cases where this dependency breaks down remain an intensely debated topic. Here we review recent mRNA–protein correlation studies in the light of the quantitative parameters of the gene expression pathway, contextual confounders and buffering mechanisms. Although protein and mRNA levels typically show reasonable correlation, we describe how transcriptomics and proteomics provide useful non-redundant readouts. Integrating both types of data can reveal exciting biology and is an essential step in refining our understanding of the principles of gene expression control.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Comprehensive analysis of key genes and pathways for biological and clinical implications in thyroid-associated ophthalmopathy
BMC Genomics Open Access 02 September 2022
Scientific Reports Open Access 05 August 2022
Transcriptomic study of anastasis for reversal of ethanol-induced apoptosis in mouse primary liver cells
Scientific Data Open Access 18 July 2022
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Abbott, S. & Fairbanks, D. J. Experiments on plant hybrids by Gregor Mendel. Genetics 204, 407–422 (2016).
Lester, G. & Bonner, D. M. The occurrence of beta-galactosidase in Escherichia coli. J. Bacteriol. 63, 759–769 (1952).
Jacob, F. & Monod, J. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3, 318–356 (1961).
Gann, A. Jacob and Monod: from operons to EvoDevo. Curr. Biol. 20, R718–R723 (2010).
Montgomery, S. B. & Dermitzakis, E. T. From expression QTLs to personalized transcriptomics. Nat. Rev. Genet. 12, 277–282 (2011).
Koch, L. Genomics: adding another dimension to gene regulation. Nat. Rev. Genet. 16, 563 (2015).
Bentley, D. L. Coupling mRNA processing with transcription in time and space. Nat. Rev. Genet. 15, 163–175 (2014).
Hentze, M. W., Castello, A., Schwarzl, T. & Preiss, T. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 19, 327–341 (2018).
Tahmasebi, S., Khoutorsky, A., Mathews, M. B. & Sonenberg, N. Translation deregulation in human disease. Nat. Rev. Mol. Cell Biol. 19, 791–807 (2018).
Teixeira, F. K. & Lehmann, R. Translational control during developmental transitions. Cold Spring Harb. Perspect. Biol. 11, a032987 (2019).
Emmott, E., Jovanovic, M. & Slavov, N. Ribosome stoichiometry: from form to function. Trends Biochem. Sci. 44, 95–109 (2019).
Schwartz, A. L. & Ciechanover, A. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu. Rev. Pharmacol. Toxicol. 49, 73–96 (2009).
Pohl, C. & Dikic, I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 366, 818–822 (2019).
Ryan, C. J. et al. High-resolution network biology: connecting sequence with function. Nat. Rev. Genet. 14, 865–879 (2013).
Mann, M. & Jensen, O. N. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21, 255–261 (2003).
Alberts, B. et al. Molecular Biology of the Cell (Garland Press, 2002).
Aebersold, R. et al. How many human proteoforms are there? Nat. Chem. Biol. 14, 206–214 (2018).
Salovska, B. et al. Isoform-resolved correlation analysis between mRNA abundance regulation and protein level degradation. Mol. Syst. Biol. 16, e9170 (2020).
Kempfer, R. & Pombo, A. Methods for mapping 3D chromosome architecture. Nat. Rev. Genet. 21, 207–226 (2019).
Goodwin, S., McPherson, J. D. & McCombie, W. R. Coming of age: ten years of next-generation sequencing technologies. Nat. Rev. Genet. 17, 333–351 (2016).
Stark, R., Grzelak, M. & Hadfield, J. RNA sequencing: the teenage years. Nat. Rev. Genet. 20, 631–656 (2019).
Aebersold, R. & Mann, M. Mass-spectrometric exploration of proteome structure and function. Nature 537, 347–355 (2016). This review provides an overview of mass spectrometry-based proteomic technologies and their biomedical applications.
Vogel, C. & Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227–232 (2012).
Liu, Y., Beyer, A. & Aebersold, R. On the dependency of cellular protein levels on mRNA abundance. Cell 165, 535–550 (2016).
Fortelny, N., Overall, C. M., Pavlidis, P. & Freue, G. V. C. Can we predict protein from mRNA levels? Nature 547, E19–E20 (2017). This study questions the utility of protein-to-mRNA ratios and argues that these are likely to be of little use when one is attempting to make within-gene estimates of protein levels from mRNA.
Franks, A., Airoldi, E. & Slavov, N. Post-transcriptional regulation across human tissues. PLoS Comput. Biol. 13, e1005535 (2017).
Gygi, S. P., Rochon, Y., Franza, B. R. & Aebersold, R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19, 1720–1730 (1999). One of the original studies attempting to correlate proteins with mRNA abundance. Gygi and colleagues note that coverage bias may greatly affect across-gene correlations.
Edfors, F. et al. Gene-specific correlation of RNA and protein levels in human cells and tissues. Mol. Syst. Biol. 12, 883 (2016).
Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382–387 (2014).
Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55–62 (2016).
Zhang, H. et al. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell 166, 755–765 (2016).
Huang, K.-L. et al. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat. Commun. 8, 14864 (2017).
Archer, T. C. et al. Proteomics, post-translational modifications, and integrative analyses reveal molecular heterogeneity within medulloblastoma subgroups. Cancer Cell 34, 396–410.e8 (2018).
Mun, D.-G. et al. Proteogenomic characterization of human early-onset gastric cancer. Cancer Cell 35, 111–124.e10 (2019).
Vasaikar, S. et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 177, 1035–1049.e19 (2019).
Khan, Z. et al. Primate transcript and protein expression levels evolve under compensatory selection pressures. Science 342, 1100–1104 (2013).
Battle, A. et al. Genomic variation. Impact of regulatory variation from RNA to protein. Science 347, 664–667 (2015). This study looks at how mRNA variation, arising from germline DNA variation in a population of humans, is buffered at the translational and protein levels.
Chick, J. M. et al. Defining the consequences of genetic variation on a proteome-wide scale. Nature 534, 500–505 (2016).
Wang, D. et al. A deep proteome and transcriptome abundance atlas of 29 healthy human tissues. Mol. Syst. Biol. 15, e8503 (2019).
Ankney, J. A., Astor Ankney, J., Muneer, A. & Chen, X. Relative and absolute quantitation in mass spectrometry–based proteomics. Annu. Rev. Anal. Chem. 11, 49–77 (2018). This review addresses the pros and cons of different absolute and relative proteomic quantification methods.
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621–628 (2008).
Fu, Y., Wu, P.-H., Beane, T., Zamore, P. D. & Weng, Z. Elimination of PCR duplicates in RNA-seq and small RNA-seq using unique molecular identifiers. BMC Genomics 19, 531 (2018).
Benjamini, Y. & Speed, T. P. Summarizing and correcting the GC content bias in high-throughput sequencing. Nucleic Acids Res. 40, e72 (2012).
Tang, H. et al. A computational approach toward label-free protein quantification using predicted peptide detectability. Bioinformatics 22, e481–e488 (2006).
Zimmer, D., Schneider, K., Sommer, F., Schroda, M. & Mühlhaus, T. Artificial intelligence understands peptide observability and assists with absolute protein quantification. Front. Plant. Sci. 9, 1559 (2018).
Peng, M. et al. Protease bias in absolute protein quantitation. Nat. Methods 9, 524–525 (2012). This study specifically interrogates intensity-based quantification methods in mass-spectrometry-based proteomics and how these may differ widely depending on the mode of enzyme digestion.
Schwanhäusser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337–342 (2011). This study combines metabolic pulse labelling and absolute quantification of both mRNAs and proteins with mathematical modelling to quantify the major stages of mammalian gene expression control.
Li, J. J., Bickel, P. J. & Biggin, M. D. System wide analyses have underestimated protein abundances and the importance of transcription in mammals. PeerJ 2, e270 (2014).
Jovanovic, M. et al. Dynamic profiling of the protein life cycle in response to pathogens. Science 347, 1259038 (2015). This study integrates absolute quantification of mRNAs and proteins along with protein turnover information in the context of LPS stimulation using ordinary differential equations to comprehensively assess gene expression regulation.
Ahrné, E., Molzahn, L., Glatter, T. & Schmidt, A. Critical assessment of proteome-wide label-free absolute abundance estimation strategies. Proteomics 13, 2567–2578 (2013).
Zeiler, M., Straube, W. L., Lundberg, E., Uhlen, M. & Mann, M. A protein epitope signature tag (PrEST) library allows SILAC-based absolute quantification and multiplexed determination of protein copy numbers in cell lines. Mol. Cell. Proteom. 11, O111.009613 (2012).
Lin, C. Y. et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56–67 (2012).
Crick, F. Central dogma of molecular biology. Nature 227, 561–563 (1970). This study provides the original postulate of the central dogma of molecular biology, not to be confused with gene expression in general.
Cobb, M. 60 years ago, Francis Crick changed the logic of biology. PLoS Biol. 15, e2003243 (2017).
Davidson, E. H. Emerging properties of animal gene regulatory networks. Nature 468, 911–920 (2010).
Lindeboom, R. G. H. et al. Integrative multi-omics analysis of intestinal organoid differentiation. Mol. Syst. Biol. 14, e8227 (2018).
Becker, K. et al. Quantifying post-transcriptional regulation in the development of Drosophila melanogaster. Nat. Commun. 9, 4970 (2018).
Ingolia, N. T., Lareau, L. F. & Weissman, J. S. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147, 789–802 (2011).
Cheng, Z. et al. Differential dynamics of the mammalian mRNA and protein expression response to misfolding stress. Mol. Syst. Biol. 12, 855 (2016).
Darzacq, X. et al. In vivo dynamics of RNA polymerase II transcription. Nat. Struct. Mol. Biol. 14, 796–806 (2007).
Hausser, J., Mayo, A., Keren, L. & Alon, U. Central dogma rates and the trade-off between precision and economy in gene expression. Nat. Commun. 10, 68 (2019). This study analyses the parametric landscape of gene expression across genes, investigating the overall strategy evolution has selected, for example, to regulate highly expressed genes.
Schwanhäusser, B., Wolf, J., Selbach, M. & Busse, D. Synthesis and degradation jointly determine the responsiveness of the cellular proteome. Bioessays 35, 597–601 (2013).
Beyer, A., Hollunder, J., Nasheuer, H.-P. & Wilhelm, T. Post-transcriptional expression regulation in the yeast Saccharomyces cerevisiae on a genomic scale. Mol. Cell. Proteomics 3, 1083–1092 (2004).
Zecha, J. et al. Peptide level turnover measurements enable the study of proteoform dynamics. Mol. Cell. Proteomics 17, 974–992 (2018).
Kristensen, A. R., Gsponer, J. & Foster, L. J. Protein synthesis rate is the predominant regulator of protein expression during differentiation. Mol. Syst. Biol. 9, 689 (2013).
Baum, K., Schuchhardt, J., Wolf, J. & Busse, D. Of gene expression and cell division time: a mathematical framework for advanced differential gene expression and data analysis. Cell Syst. 9, 569–579 (2019). This study formalizes the role of cell cycle time in the context of gene expression.
Wilhelm, M. et al. Mass-spectrometry-based draft of the human proteome. Nature 509, 582–587 (2014). This study presents an in-depth proteomics and transcriptomics dataset of 12 tissues and is one of the first to posit that protein-to-mRNA ratios can be used to estimate absolute protein abundances from mRNA.
Eraslan, B. et al. Quantification and discovery of sequence determinants of protein-per-mRNA amount in 29 human tissues. Mol. Syst. Biol. 15, e8513 (2019).
Buszczak, M., Signer, R. A. J. & Morrison, S. J. Cellular differences in protein synthesis regulate tissue homeostasis. Cell 159, 242–251 (2014).
Peshkin, L. et al. On the relationship of protein and mRNA dynamics in vertebrate embryonic development. Dev. Cell 35, 383–394 (2015).
Xiao, H. et al. Differential proteomic analysis of human saliva using tandem mass tags quantification for gastric cancer detection. Sci. Rep. 6, 22165 (2016).
Zhao, M. et al. A comprehensive analysis and annotation of human normal urinary proteome. Sci. Rep. 7, 3024 (2017).
Cso˝sz, É. et al. Quantitative body fluid proteomics in medicine - a focus on minimal invasiveness. J. Proteomics 153, 30–43 (2017).
Geyer, P. E., Holdt, L. M., Teupser, D. & Mann, M. Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol. 13, 942 (2017).
Yao, C. et al. Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease. Nat. Commun. 9, 3268 (2018).
Meissner, F., Scheltema, R. A., Mollenkopf, H.-J. & Mann, M. Direct proteomic quantification of the secretome of activated immune cells. Science 340, 475–478 (2013).
Suhre, K. et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat. Commun. 8, 14357 (2017).
Moritz, C. P., Mühlhaus, T., Tenzer, S., Schulenborg, T. & Friauf, E. Poor transcript-protein correlation in the brain: negatively correlating gene products reveal neuronal polarity as a potential cause. J. Neurochem. 149, 582–604 (2019).
Zappulo, A. et al. RNA localization is a key determinant of neurite-enriched proteome. Nat. Commun. 8, 583 (2017).
Holt, C. E., Martin, K. C. & Schuman, E. M. Local translation in neurons: visualization and function. Nat. Struct. Mol. Biol. 26, 557–566 (2019).
Chekulaeva, M. & Landthaler, M. Eyes on translation. Mol. Cell 63, 918–925 (2016).
Sysoev, V. O. et al. Global changes of the RNA-bound proteome during the maternal-to-zygotic transition in Drosophila. Nat. Commun. 7, 12128 (2016).
Stoeckius, M. et al. Global characterization of the oocyte-to-embryo transition in Caenorhabditis elegans uncovers a novel mRNA clearance mechanism. EMBO J. 33, 1751–1766 (2014).
Koch, S., Acebron, S. P., Herbst, J., Hatiboglu, G. & Niehrs, C. Post-transcriptional Wnt signaling governs epididymal sperm maturation. Cell 163, 1225–1236 (2015).
Liu, X. et al. Regulation of mitochondrial biogenesis in erythropoiesis by mTORC1-mediated protein translation. Nat. Cell Biol. 19, 626–638 (2017).
Gautier, E.-F. et al. Comprehensive proteomic analysis of human erythropoiesis. Cell Rep. 16, 1470–1484 (2016).
Nguyen, A. T. et al. UBE2O remodels the proteome during terminal erythroid differentiation. Science 357, eaan0218 (2017).
Yanagitani, K., Juszkiewicz, S. & Hegde, R. S. UBE2O is a quality control factor for orphans of multiprotein complexes. Science 357, 472–475 (2017). Nguyen et al. (2017) and Yanagitani et al. (2017) characterize the mechanism of action and role of UBE2O as a ubiquitin ligase responsible for clearing surplus protein complex subunits.
Mathieson, T. et al. Systematic analysis of protein turnover in primary cells. Nat. Commun. 9, 689 (2018).
Dörrbaum, A. R., Kochen, L., Langer, J. D. & Schuman, E. M. Local and global influences on protein turnover in neurons and glia. eLife 7, e34202 (2018).
Marguerat, S. et al. Quantitative analysis of fission yeast transcriptomes and proteomes in proliferating and quiescent cells. Cell 151, 671–683 (2012).
Félix, M.-A. & Barkoulas, M. Pervasive robustness in biological systems. Nat. Rev. Genet. 16, 483–496 (2015).
Rogers, J. & Gibbs, R. A. Comparative primate genomics: emerging patterns of genome content and dynamics. Nat. Rev. Genet. 15, 347–359 (2014).
Waszak, S. M. et al. Population variation and genetic control of modular chromatin architecture in humans. Cell 162, 1039–1050 (2015).
Raj, A., Peskin, C. S., Tranchina, D., Vargas, D. Y. & Tyagi, S. Stochastic mRNA synthesis in mammalian cells. PLoS Biol. 4, e309 (2006).
Raser, J. M. & O’Shea, E. K. Control of stochasticity in eukaryotic gene expression. Science 304, 1811–1814 (2004).
Kustatscher, G., Grabowski, P. & Rappsilber, J. Pervasive coexpression of spatially proximal genes is buffered at the protein level. Mol. Syst. Biol. 13, 937 (2017). This study outlines how covariation in mRNA owing to chromosomal location of source genes is lost at the protein level.
Geiger, T., Cox, J. & Mann, M. Proteomic changes resulting from gene copy number variations in cancer cells. PLoS Genet. 6, e1001090 (2010). This is the first systematic analysis showing that the levels of some proteins are resistant to DNA copy number changes in mammalian cell lines.
Stingele, S. et al. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol. Syst. Biol. 8, 608 (2012).
Dephoure, N. et al. Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast. eLife 3, e03023 (2014).
Gonçalves, E. et al. Widespread post-transcriptional attenuation of genomic copy-number variation in cancer. Cell Syst. 5, 386–398.e4 (2017). This study presents a reanalysis of Clinical Proteomic Tumor Analysis Consortium (CPTAC) breast, ovarian and colorectal cancer studies and finds that ~20–30% of mRNA changes caused by aneuploidy are buffered at the protein level and further leverage this information to predict protein–protein interactions.
Liu, Y. et al. Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells. Nat. Commun. 8, 1212 (2017).
Schlattl, A., Anders, S., Waszak, S. M., Huber, W. & Korbel, J. O. Relating CNVs to transcriptome data at fine resolution: assessment of the effect of variant size, type, and overlap with functional regions. Genome Res. 21, 2004–2013 (2011).
Fehrmann, R. S. N. et al. Gene expression analysis identifies global gene dosage sensitivity in cancer. Nat. Genet. 47, 115–125 (2015). This study demonstrates, across tens of thousands of microarray and RNA-seq samples, the direct and dosage-sensitive effects of somatic copy number alterations (aneuploidy) on mRNA and underlines almost no buffering between the DNA and mRNA levels.
Grönlund, A., Lötstedt, P. & Elf, J. Transcription factor binding kinetics constrain noise suppression via negative feedback. Nat. Commun. 4, 1864 (2013).
Müller-McNicoll, M., Rossbach, O., Hui, J. & Medenbach, J. Auto-regulatory feedback by RNA-binding proteins. J. Mol. Cell Biol. 11, 930–939 (2019).
Jumaa, H. & Nielsen, P. J. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J. 16, 5077–5085 (1997). This is one of the early studies analysing the autoregulatory capability of many splicing factors.
Lareau, L. F., Inada, M., Green, R. E., Wengrod, J. C. & Brenner, S. E. Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446, 926–929 (2007).
de Bie, P. & Ciechanover, A. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms. Cell Death Differ. 18, 1393–1402 (2011).
Signor, S. A. & Nuzhdin, S. V. The evolution of gene expression in cis and trans. Trends Genet. 34, 532–544 (2018).
Bader, D. M. et al. Negative feedback buffers effects of regulatory variants. Mol. Syst. Biol. 11, 785 (2015).
Battich, N., Stoeger, T. & Pelkmans, L. Control of transcript variability in single mammalian cells. Cell 163, 1596–1610 (2015).
Artieri, C. G. & Fraser, H. B. Evolution at two levels of gene expression in yeast. Genome Res. 24, 411–421 (2014).
McManus, C. J., May, G. E., Spealman, P. & Shteyman, A. Ribosome profiling reveals post-transcriptional buffering of divergent gene expression in yeast. Genome Res. 24, 422–430 (2014).
Taggart, J. C. & Li, G.-W. Production of protein-complex components is stoichiometric and lacks general feedback regulation in eukaryotes. Cell Syst. 7, 580–589.e4 (2018).
Juszkiewicz, S. & Hegde, R. S. Quality control of orphaned proteins. Mol. Cell 71, 443–457 (2018).
McShane, E. et al. Kinetic analysis of protein stability reveals age-dependent degradation. Cell 167, 803–815.e21 (2016).
Taggart, J. C., Zauber, H., Selbach, M., Li, G.-W. & McShane, E. Keeping the proportions of protein complex components in check. Cell Syst. 10, 125–132 (2020).
Santaguida, S., Vasile, E., White, E. & Amon, A. Aneuploidy-induced cellular stresses limit autophagic degradation. Genes Dev. 29, 2010–2021 (2015).
Santaguida, S. et al. Chromosome mis-segregation generates cell-cycle-arrested cells with complex karyotypes that are eliminated by the immune system. Dev. Cell 41, 638–651.e5 (2017).
Stuart, T. & Satija, R. Integrative single-cell analysis. Nat. Rev. Genet. 20, 257–272 (2019).
Marx, V. A dream of single-cell proteomics. Nat. Methods 16, 809–812 (2019).
Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865–868 (2017).
Spitzer, M. H. & Nolan, G. P. Mass cytometry: single cells, many features. Cell 165, 780–791 (2016).
Budnik, B., Levy, E., Harmange, G. & Slavov, N. SCoPE-MS: mass spectrometry of single mammalian cells quantifies proteome heterogeneity during cell differentiation. Genome Biol. 19, 161 (2018).
Popovic, D., Koch, B., Kueblbeck, M., Ellenberg, J. & Pelkmans, L. Multivariate control of transcript to protein variability in single mammalian cells. Cell Syst. 7, 398–411.e6 (2018).
Albayrak, C. et al. Digital quantification of proteins and mRNA in single mammalian cells. Mol. Cell 61, 914–924 (2016).
Genshaf, A. S. et al. Multiplexed, targeted profiling of single-cell proteomes and transcriptomes in a single reaction. Genome Biol. 17, 188 (2016).
Peterson, V. M. et al. Multiplexed quantification of proteins and transcripts in single cells. Nat. Biotechnol. 35, 936–939 (2017).
Sopko, R. et al. Mapping pathways and phenotypes by systematic gene overexpression. Mol. Cell 21, 319–330 (2006).
Brennan, C. M. et al. Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells. Genes Dev. 33, 1031–1047 (2019).
Klosin, A. et al. Phase separation provides a mechanism to reduce noise in cells. Science 367, 464–468 (2020).
Nusinow, D. P. et al. Quantitative proteomics of the cancer cell line encyclopedia. Cell 180, 387–402.e16 (2020).
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043–1048 (2006).
Ben-David, U. et al. The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis. Nat. Commun. 7, 12160 (2016).
Gehre, M., Buccitelli, C., Diaz, N., Korbel, J. & Noh, K.-M. Efficient strategies to detect genome editing and integrity in CRISPR-Cas9 engineered ESCs. Preprint at bioRxiv https://doi.org/10.1101/635151 (2019).
Wang, J. et al. Proteome profiling outperforms transcriptome profiling for coexpression based gene function prediction. Mol. Cell. Proteom. 16, 121–134 (2017).
Lapek, J. D. Jr et al. Detection of dysregulated protein-association networks by high-throughput proteomics predicts cancer vulnerabilities. Nat. Biotechnol. 35, 983–989 (2017).
Kustatscher, G. et al. Co-regulation map of the human proteome enables identification of protein functions. Nat. Biotechnol. 37, 1361–1371 (2019).
Roumeliotis, T. I. et al. Genomic determinants of protein abundance variation in colorectal cancer cells. Cell Rep. 20, 2201–2214 (2017).
Romanov, N. et al. Disentangling genetic and environmental effects on the proteotypes of individuals. Cell 177, 1308–1318.e10 (2019).
Ori, A. et al. Spatiotemporal variation of mammalian protein complex stoichiometries. Genome Biol. 17, 47 (2016).
Doll, S., Gnad, F. & Mann, M. The case for proteomics and phospho-proteomics in personalized cancer medicine. Proteomics Clin. Appl. 13, e1800113 (2019).
Welker, F. et al. Enamel proteome shows that Gigantopithecus was an early diverging pongine. Nature 576, 262–265 (2019).
Olsen, J. V. et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635–648 (2006).
Meyer, K. & Selbach, M. Quantitative affinity purification mass spectrometry: a versatile technology to study protein-protein interactions. Front. Genet. 6, 237 (2015).
Yang, J., Wagner, S. A. & Beli, P. Illuminating spatial and temporal organization of protein interaction networks by mass spectrometry-based proteomics. Front. Genet. 6, 344 (2015).
Dettmer, K., Aronov, P. A. & Hammock, B. D. Mass spectrometry-based metabolomics. Mass. Spectrom. Rev. 26, 51–78 (2007).
Zelezniak, A. et al. Machine learning predicts the yeast metabolome from the quantitative proteome of kinase knockouts. Cell Syst. 7, 269–283.e6 (2018).
Senft, D., Qi, J. & Ronai, Z. A. Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat. Rev. Cancer 18, 69–88 (2017).
Krönke, J. et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301–305 (2014).
Lu, G. et al. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343, 305–309 (2014).
Chamberlain, P. P. & Hamann, L. G. Development of targeted protein degradation therapeutics. Nat. Chem. Biol. 15, 937–944 (2019).
Tang, Y.-C., Williams, B. R., Siegel, J. J. & Amon, A. Identification of aneuploidy-selective antiproliferation compounds. Cell 144, 499–512 (2011).
Ben-David, U. & Amon, A. Context is everything: aneuploidy in cancer. Nat. Rev. Genet. 21, 44–62 (2020).
Hasin, Y., Seldin, M. & Lusis, A. Multi-omics approaches to disease. Genome Biol. 18, 83 (2017).
Vitrinel, B. et al. Exploiting interdata relationships in next-generation proteomics analysis. Mol. Cell. Proteomics 18, S5–S14 (2019).
Dölken, L. et al. High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA 14, 1959–1972 (2008).
Herzog, V. A. et al. Thiol-linked alkylation of RNA to assess expression dynamics. Nat. Methods 14, 1198–1204 (2017).
Mann, M. Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 7, 952–958 (2006).
Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58–63 (2008).
Schwanhäusser, B., Gossen, M., Dittmar, G. & Selbach, M. Global analysis of cellular protein translation by pulsed SILAC. Proteomics 9, 205–209 (2009).
Doherty, M. K., Hammond, D. E., Clague, M. J., Gaskell, S. J. & Beynon, R. J. Turnover of the human proteome: determination of protein intracellular stability by dynamic SILAC. J. Proteome Res. 8, 104–112 (2009).
Boisvert, F.-M. et al. A quantitative spatial proteomics analysis of proteome turnover in human cells. Mol. Cell. Proteomics 11, M111.011429 (2012).
Savitski, M. M. et al. Multiplexed proteome dynamics profiling reveals mechanisms controlling protein homeostasis. Cell 173, 260–274.e25 (2018).
Dieterich, D. C., Link, A. J., Graumann, J., Tirrell, D. A. & Schuman, E. M. Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT). Proc. Natl Acad. Sci. USA 103, 9482–9487 (2006).
Eichelbaum, K., Winter, M., Berriel Diaz, M., Herzig, S. & Krijgsveld, J. Selective enrichment of newly synthesized proteins for quantitative secretome analysis. Nat. Biotechnol. 30, 984–990 (2012).
Brar, G. A. & Weissman, J. S. Ribosome profiling reveals the what, when, where and how of protein synthesis. Nat. Rev. Mol. Cell Biol. 16, 651–664 (2015).
van Heesch, S. et al. The translational landscape of the human heart. Cell 178, 242–260.e29 (2019).
Calviello, L. et al. Detecting actively translated open reading frames in ribosome profiling data. Nat. Methods 13, 165–170 (2016).
Diament, A. et al. The extent of ribosome queuing in budding yeast. PLoS Comput. Biol. 14, e1005951 (2018).
Riba, A. et al. Protein synthesis rates and ribosome occupancies reveal determinants of translation elongation rates. Proc. Natl Acad. Sci. USA 116, 15023–15032 (2019).
Duncan, C. D. S. & Mata, J. Effects of cycloheximide on the interpretation of ribosome profiling experiments in Schizosaccharomyces pombe. Sci. Rep. 7, 10331 (2017).
Ingolia, N. T. Tracking the missing footprints of idle ribosomes. Cell Syst. 4, 583–584 (2017).
Liu, T.-Y. et al. Time-resolved proteomics extends ribosome profiling-based measurements of protein synthesis dynamics. Cell Syst. 4, 636–644.e9 (2017).
Anscombe, F. J. Graphs in statistical analysis. Am. Stat. 27, 17–21 (1973).
The authors acknowledge the extensive contributions of the scientific community to the topic of this Review and apologize for being unable to reference all pertinent articles. The authors thank P. Mertins, J. Wolf, D. Harnett (all from the Max Delbrück Center for Molecular Medicine) and E. McShane (Harvard Medical School) for feedback. They also thank T. Melder (Max Delbrück Center for Molecular Medicine) for help with the chemical structures and all other members of the Selbach laboratory for helpful discussions.
The authors declare no competing interests.
Peer review information
Nature Reviews Genetics thanks Gary Churchill, Yansheng Liu and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The complement of DNA possessed by an organism.
The observable characteristics of an organism, which results from the genotype and its interaction with the environment.
- Non-coding RNAs
RNAs transcribed from the genome that do not serve as templates for proteins (for example, microRNAs).
- Ubiquitin–proteasome system
An ancient system conserved across species that is responsible for the regulated catabolism of individual proteins. Classes of enzymes (E1, E2 and E3) function in specifically ubiquitylating proteins within the cell, thus targeting these clients for destruction by the proteasome.
A form of cellular catabolism that is responsible for the removal of large cellular components (for instance, protein aggregates or damaged organelles). Autophagy involves the inclusion of these components within double-membraned vesicles (termed ‘autophagosomes’), which then undergo fusion with lysosomes.
- Omics technologies
A generic term referring to the multitude of technologies to systematically measure multiple biological molecules simultaneously.
The closeness of repeated measurements to each other. High precision means that measurements are highly reproducible.
The closeness of the average of repeated measurements to the true value. High accuracy means that the measurements are on average in good agreement with the true quantity.
- GC correction
A computational approach used to account for sequencing depth biases due to the guanine/cytosine composition of a particular region of the genome.
- Shotgun proteomics
In ‘shotgun’ or ‘bottom-up’ proteomics, the proteins in a sample are cleaved into peptides before being analysed by mass spectrometry. Peptides are simpler than proteins, which facilitates their analysis by mass spectrometry and makes the shotgun approach particularly popular.
Enzymes that digest proteins into smaller fragments. In shotgun proteomics, proteins are digested into peptides by sequence-specific proteases (such as trypsin, which cleaves proteins at the carboxy-terminal side of lysine and arginine residues).
(LPS). A structural component of the outer membrane of Gram-negative bacteria. LPS may be sensed by specialized cells of the mammalian immune system (for example, dendritic cells), triggering both transcriptional and post-transcriptional responses so as to combat an imminent infection.
- Transcription rates
The rates at which mRNA transcripts are generated for given genes.
The times it takes for a set of molecules (mRNAs and proteins in the context of this Review) to reduce in number to half of their original quantity via degradation. The term implies that degradation follows first-order kinetics, which is not always true.
- Translation rate constants
The rates at which proteins are synthesized, as a function of transcript number (expressed as protein copies per mRNA per hour).
The complement of the proteome produced and secreted by cells.
- Polarized cells
A difference in the distribution of cellular materials across a cell (for example, of organelles or proteins).
- Maternal to zygotic transition
The point at which a developing zygote transitions from relying on maternally imparted proteins and mRNAs to gene products encoded by and transcribed from its own genome.
The process involving the development and differentiation of red blood cells (erythrocytes).
Referring to quiescence, which is a cellular state occurring in most organisms that is characterized by a temporary exit from the cell cycle.
- Quantitative trait loci
(QTLs). Loci in the genome for which the genotype correlates with variation in a quantifiable trait of an organism. Expression QTLs (eQTLs) and protein QTLs (pQTLs) are loci that correlate with variation in mRNA and protein levels, respectively.
The abnormal copy number of either a segment of or the entire chromosome in the genome.
With reference to protein complexes, the proportion of the individual subunits that make up a protein complex.
About this article
Cite this article
Buccitelli, C., Selbach, M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet 21, 630–644 (2020). https://doi.org/10.1038/s41576-020-0258-4
Comprehensive analysis of key genes and pathways for biological and clinical implications in thyroid-associated ophthalmopathy
BMC Genomics (2022)
Identifying causal genes for stroke via integrating the proteome and transcriptome from brain and blood
Journal of Translational Medicine (2022)
The fiber diameter traits of Tibetan cashmere goats are governed by the inherent differences in stress, hypoxic, and metabolic adaptations: an integrative study of proteome and transcriptome
BMC Genomics (2022)
Nature Reviews Cancer (2022)
Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood
Molecular Psychiatry (2022)